Nicotine
A to Z Drug Facts
Nicotine |
(NIK-oh-TEEN) |
Habitrol, Nicoderm, Nicorette, Nicorette DS, Nicotrol, Nicotrol NS, Nicotrol Inhaler, ProStep, Nicorette Plus |
Class: Smoking deterrent |
Action Reduces nicotine withdrawal symptoms by providing nicotine levels lower than those associated with smoking.
Indications Aid to smoking cessation. Part of comprehensive behavioral smoking-cessation program.
Contraindications Non-smokers; during immediate post-MI period; life-threatening arrhythmias; severe or worsening angina pectoris; active temporomandibular joint disease (nicotine Polacrilex [gum]).
TRANSDERMAL PATCHES
ADULTS: Topical Apply one patch daily. Start with 14 to 22 mg/day patches. Gradually decrease dose by using smaller dose patches over 2 to 5 mo.
NICOTINE NICORETTE (NICOTINE GUM)
ADULTS: PO 4 mg pieces (maximum 20 pieces/day) for highly dependent patients. For others, 2 mg pieces (maximum 30 pieces/day). Chew 1 piece prn or on fixed schedule of 1 piece q 1 to 2 hr initially. Initiate gradual weaning from treatment after 2 to 3 mo and complete withdrawal by 4 to 6 mo.
NICOTINE PUMP SPRAY
ADULTS: Spray One dose is 1 mg (2 sprays, one in each nostril). 1 to 2 doses/hr to a maximum of 5 doses/hr or 40 doses/day. Treatment should last < 3 months.
Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propanolol, theophylline: Smoking tends to increase metabolism and may lower blood levels of these drugs or others. Smoking cessation, with or without nicotine medication, may reverse these effects. Food: Effective absorption of nicotine gum depends on mildly alkaline saliva. Coffee, cola and other drinks or food may reduce salivary pH and should probably be avoided 15 min before and during chewing of gum.
Lab Test Interferences None well documented.
CV: Edema; flushing; hypertension; palpitations; tachyarrhythmias; tachycardia; MI; CHF; cardiac arrest; cerebrovascular accident. CNS: Insomnia; dizziness; lightheadedness; irritability; headache; impaired concentration; confusion; convulsions; depression; paresthesia; abnormal dreams. DERM: Erythema; rash; itching; urticaria. EENT: Buccal cavity irritation; mouth or throat soreness or dryness. With gum chewing: traumatic injury to oral mucosa or teeth; jaw ache; changes in taste perception. GI: GI distress; belching; indigestion; nausea; vomiting; excess salivation; hiccoughs; anorexia; constipation; diarrhea. HEPA: Alterations of liver function tests. RESP: Increased cough; pharyngitis; sinusitis; difficulty breathing; hoarseness; sneezing. OTHER: Pain; myalgia; arthralgia; dysmenorrhea.
Pregnancy: Category C (nicotine polacrilex); Category D (transdermal nicotine). Lactation: Excreted in breast milk. Children: Safety and efficacy not established. Elderly or debilitated patients: May be more susceptible to adverse effects. Abuse/Dependence: Transference of nicotine dependence from smoking to deterrent product exists. If patient continues to smoke while on nicotine therapy, patient may experience severe effects because of higher nicotine levels. Cardiovascular effects: Patients with coronary heart disease, serious cardiac arrhythmias, systemic hypertension or vasospastic disease need to be carefully evaluated and monitored closely because of cardiac effects. Dental problems: Might be exacerbated by chewing nicotine gum. Endocrine effects: Use with caution in patients with hyperthyroidism, pheochromocytoma or insulin-dependent diabetes because of action of nicotine on adrenal medulla. GI effects: May delay healing in patients with peptic ulcer disease. Hepatic impairment: May reduce nicotine clearance.
PATIENT CARE CONSIDERATIONS |
|
Transdermal System
Nicotine Chewing Gum
Nasal Spray
|
Nasal Spray
Books@Ovid
Copyright © 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts